Epigenetic mechanisms of breast cancer: an update of the current knowledge

被引：0

作者：

Karsli-Ceppioglu, Seher ^{[1
,2
,3
]}

Dagdemir, Aslihan ^{[1
,2
]}

Judes, Gaelle ^{[1
,2
]}

Ngollo, Marjolaine ^{[1
,2
]}

Penault-Llorca, Frederique ^{[1
,2
]}

Pajon, Amaury ^{[1
,2
]}

Bignon, Yves-Jean ^{[1
,2
]}

Bernard-Gallon, Dominique ^{[1
,2
]}

机构：

[1] Ctr Jean Perrin CBRV, Dept Oncogenet, F-63000 Clermont Ferrand, France

[2] EA 4677 ERTICA Univ Auvergne, F-63000 Clermont Ferrand, France

[3] Marmara Univ, Dept Toxicol, Fac Pharm, Istanbul, Turkey

来源：

EPIGENOMICS | 2014年 / 6卷 / 06期

关键词：

BRCA1; breast cancer; DNA methylation; epigenetics; epigenetic therapy; estrogen; EZH2; histone modification; BRCA1 PROMOTER METHYLATION; ESTROGEN-RECEPTOR EXPRESSION; CPG ISLAND HYPERMETHYLATION; TUMOR-SUPPRESSOR GENES; PERIPHERAL-BLOOD CELLS; SPORADIC BREAST; DNA METHYLATION; HISTONE MODIFICATIONS; ABERRANT METHYLATION; DE-NOVO;

D O I：

10.2217/EPI.14.59

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Epigenetic alterations are heritable changes in gene expression that occur without causing any change in DNA sequence. They are important key factors for cancer development and prognosis. Breast cancer is induced by the accumulation of altered gene regulation. Besides genetic mutations, epigenetics mechanisms have an important role in breast cancer tumorigenesis. Investigations related with aberrant epigenetic regulations in breast cancer focus on initiating molecular mechanisms in cancer development, identification of new biomarkers to predict breast cancer aggressiveness and the potential of epigenetic therapy. In this review, we will summarize the recent knowledge about the role of epigenetic alterations related with DNA methylation and histone modification in breast cancer. In addition, altered regulation of breast cancer specific genes and the potential of epigenetic therapy will be discussed according to epigenetic mechanisms.

引用

页码：651 / 664

页数：14

共 50 条

[21] Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
Sher, Gulab
Salman, Nadia Aziz
Khan, Abdul Q.
Prabhu, Kirti S.
Raza, Afsheen
Kulinski, Michal
Dermime, Said
Haris, Mohammad
Junejo, Kulsoom
Uddin, Shahab
SEMINARS IN CANCER BIOLOGY, 2022, 83 : 152 - 165
[22] Genetic factors and epigenetic mechanisms of longevity: current perspectives
Lazarus, Jessica
Mather, Karen A.
Thalamuthu, Anbupalam
Kwok, John B. J.
EPIGENOMICS, 2015, 7 (08) : 1339 - 1349
[23] Beyond genetics: Exploring the role of epigenetic alterations in breast cancer
Prabhu, Kirti S.
Sadida, Hana Q.
Kuttikrishnan, Shilpa
Junejo, Kulsoom
Bhat, Ajaz A.
Uddin, Shahab
PATHOLOGY RESEARCH AND PRACTICE, 2024, 254
[24] The value of epigenetic biomarkers in breast cancer
Parrella, Paola
BIOMARKERS IN MEDICINE, 2018, 12 (09) : 937 - 940
[25] Epigenetic regulation and cancer ( Review)
Chen, Q. W.
Zhu, X. Y.
Li, Y. Y.
Meng, Z. Q.
ONCOLOGY REPORTS, 2014, 31 (02) : 523 - 532
[26] Targeting epigenetic regulatory mechanisms in cancer chemoprevention
Fay, JR
Crowell, JA
Kopelovich, L
EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (02) : 315 - 328
[27] Impact of Stilbenes as Epigenetic Modulators of Breast Cancer Risk and Associated Biomarkers
Ganguly, Sebanti
Arora, Itika
Tollefsbol, Trygve O.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
[28] Epigenetic Mechanisms Influencing Therapeutic Response in Breast Cancer
Arruabarrena-Aristorena, Amaia
Toska, Eneda
FRONTIERS IN ONCOLOGY, 2022, 12
[29] Epigenetic mechanisms in anti-cancer actions of bioactive food components - the implications in cancer prevention
Stefanska, B.
Karlic, H.
Varga, F.
Fabianowska-Majewska, K.
Haslberger, A. G.
BRITISH JOURNAL OF PHARMACOLOGY, 2012, 167 (02) : 279 - 297
[30] Epigenetic regulation of estrogen signaling in breast cancer
Hervouet, Eric
Cartron, Pierre-Francois
Jouvenot, Michele
Delage-Mourroux, Regis
EPIGENETICS, 2013, 8 (03) : 237 - 245

← 1 2 3 4 5 →